Celebrity Inventors
Penn Jillette of Penn and Teller fame has patented a "Hydro-Therapeutic Stimulator", which uses a hot tub for stimulation.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5288730 | Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy Compounds of formula (I), and salts and prodrugs thereof: ##STR1## wherein Q is the residue of an optionally substituted azabicyclic ring system; X represents oxa or thia; Y represents H or hydroxy; R1 represents phenyl or thienyl, either of wh... | 02/22/1994 |
| 5235066 | FK-506 type macrolide intermediate An intermediate, useful in the conversion of FK-506 to FK-525 and analogous 23-membered ring macrolides, of the structure: ##STR1##... | 08/10/1993 |
| 5202258 | Immunosuppressant-producing culture Described is a new microorganism, Actinoplanacete sp., (Merck Culture Collection MA 6559) ATCC No. 53771. The microorganism acts as a demethylating agent and can produce the new immunosuppressants, "demethomycin" (L-682,993) a C-31 demethylated analog of ... | 04/13/1993 |
| 5196352 | New FK-506 cytosolic binding protein A new homogeneous cytosolic binding (HCB) protein, having a specific binding activity of about 26 μg FK-506 per mg protein and a molecular weight of about 10-12 kilodaltons, reversibly binds the immunosuppressant FK-506 but not cyclosporine A (CSA). The ... | 03/23/1993 |
| 5183815 | Bone acting agents Described are new agents for treating bone disorders associated with a reduction in bone mass and abnormalities in bone resportion or bone formation including osteoporosis. Paget's disease, bone metastases and malignant hypercalcemia. The agents are hydro... | 02/02/1993 |
| 5164525 | Synthetic process for FK-506 type macrolide intermediates A process for the conversion of FK-506 (I,R=allyl;1) to FK-525 (XV) and analogous 23-membered ring macrolides differing in the C.1-N.7 segment of the molecule (e.g. XVI) and is also applicable to the analogs FK-523 (XVII) and FK-520 (XVIII). The overall p... | 11/17/1992 |
| 5151429 | 17ଲ-acyl-4-aza-5-androst-1-ene-3-ones as 5 reductase inhibitors 17ଲ-Acyl-4-aza-5-androst-1-en-3-ones of the formula: ##STR1## wherein R is selected from hydrogen, methyl and ethyl and R2 is a monovalent radical selected from straight and branched chain alkyl of from 1-12 carbons, or monocyclic ... | 09/29/1992 |
| 5149701 | C-31 methylated FR-900520 cyclic hemiketal immunosuppressant agents Described is a process for producing a new immunosuppressant, a C-31 desmethyl, C-19/C-22 cyclic hemiketal biotransformation analog (Compound I) of FR-900520, under novel fermentation conditions utilizing the novel microorganism, Streptomyces, lavendulae ... | 09/22/1992 |
| 5138063 | 17ଲ-methoxycarbonyl-4-aza-androsten-1-en-3-ones 17ଲ-Acyl-4-aza-5-androst-1-in-3-ones of the formula: ##STR1## wherein R is selected from hydrogen, methyl and ethyl R2 is methoxy, a monovalent radical selected from straight and branched chain alkyl of from 1-12 carbons, or m... | 08/11/1992 |
| 5120742 | 17 ଲ-acyl-4-aza-5 -androst-1-ene-3-ones as 5 -reductase inhibitors 17ଲ-Acyl-4-aza-5-Androst-1-end-3-ones of the formula: ##STR1## wherein R is selected from hydrogen, methyl and ethyl and R3 is cycloalkyl of from 4-8 carbons; and pharmaceutical formulation of the above compounds are active as test... | 06/09/1992 |
| 5049562 | 17ଲ-acyl-4-aza-5-androst-1-ene-3-ones as 5-reductase inhibitors 17ଲ-Acyl-4-aza-5-androst-1-ene-3-ones of the formula ##STR1## wherein R is selected from hydrogen, methyl and ethyl and R2 is monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or ... | 09/17/1991 |
| 5021575 | Method for introducing a 1,2 double bond into azasteroids A process for introducing a 1,2 double bond into a compound of the formula ##STR1## which comprises the process of (a) treating the compound of formula I with oxalyl chloride; (b) brominating the product of step (a) followed by in situ dehydrobromina... | 06/04/1991 |
| 5019651 | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof An improved process is described for the preparation of 4-amino-1-hydroxybutylidene-1,1-bisophosphonic acid (ABP) or salts thereof which comprises: (a) reacting 4-aminobutyric acid with a mixture of phosphorous acid and PCl3 in the presence of ... | 05/28/1991 |
